430 related articles for article (PubMed ID: 24506717)
1. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
2. [Current approaches to explain the virulence of Acinetobacter baumannii].
Aşık G
Mikrobiyol Bul; 2011 Apr; 45(2):371-80. PubMed ID: 21644082
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
5. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.
Boone RL; Whitehead B; Avery TM; Lu J; Francis JD; Guevara MA; Moore RE; Chambers SA; Doster RS; Manning SD; Townsend SD; Dent L; Marshall D; Gaddy JA; Damo SM
BMC Microbiol; 2021 Jan; 21(1):21. PubMed ID: 33422000
[TBL] [Abstract][Full Text] [Related]
6. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Rodríguez-Baño J; Martí S; Soto S; Fernández-Cuenca F; Cisneros JM; Pachón J; Pascual A; Martínez-Martínez L; McQueary C; Actis LA; Vila J;
Clin Microbiol Infect; 2008 Mar; 14(3):276-8. PubMed ID: 18190568
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
8. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii.
King LB; Swiatlo E; Swiatlo A; McDaniel LS
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):414-21. PubMed ID: 19220466
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.
Gordon NC; Wareham DW
Int J Antimicrob Agents; 2010 Mar; 35(3):219-26. PubMed ID: 20047818
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii.
Mak JK; Kim MJ; Pham J; Tapsall J; White PA
J Antimicrob Chemother; 2009 Jan; 63(1):47-54. PubMed ID: 18988680
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Cevahir N; Kaleli I; Demir M; Yildirim U; Cevik E; Gürbüz M
Mikrobiyol Bul; 2006 Jul; 40(3):251-5. PubMed ID: 17001855
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of biofilm production, gelatinase activity, and mannose-resistant hemagglutination in Acinetobacter baumannii strains.
Cevahir N; Demir M; Kaleli I; Gurbuz M; Tikvesli S
J Microbiol Immunol Infect; 2008 Dec; 41(6):513-8. PubMed ID: 19255696
[TBL] [Abstract][Full Text] [Related]
15. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
17. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.
Lee HW; Koh YM; Kim J; Lee JC; Lee YC; Seol SY; Cho DT; Kim J
Clin Microbiol Infect; 2008 Jan; 14(1):49-54. PubMed ID: 18005176
[TBL] [Abstract][Full Text] [Related]
18. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
[TBL] [Abstract][Full Text] [Related]
20. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals.
Wroblewska MM; Sawicka-Grzelak A; Marchel H; Luczak M; Sivan A
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):140-4. PubMed ID: 18400015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
